Evidence map›Paper›PMID 31890348›Full record

ArticleTranslational vision science & technology2019

Topical Brimonidine or Intravitreal BDNF, CNTF, or bFGF Protect Cones Against Phototoxicity.

Francisco J Valiente-Soriano, Arturo Ortín-Martínez, Johnny Di Pierdomenico, Diego García-Ayuso, Alejandro Gallego-Ortega, Juan A Miralles de Imperial-Ollero, Manuel Jiménez-López, María Paz Villegas-Pérez, Larry A Wheeler, Manuel Vidal-Sanz

Open access · goldAbstract read
In one paragraph

Article in Translational vision science & technology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Cone Photoreceptor Loss in Light-Damaged Albino Rats.International journal of molecular sciences · 2022
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Francisco J Valiente-SorianoDepartamento de Oftalmología, Facultad de Medicina, Universidad de Murcia, e Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca), Murcia, Spain.
Arturo Ortín-MartínezDepartamento de Oftalmología, Facultad de Medicina, Universidad de Murcia, e Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca), Murcia, Spain.
Johnny Di PierdomenicoDepartamento de Oftalmología, Facultad de Medicina, Universidad de Murcia, e Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca), Murcia, Spain.
Diego García-AyusoDepartamento de Oftalmología, Facultad de Medicina, Universidad de Murcia, e Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca), Murcia, Spain.
Alejandro Gallego-OrtegaDepartamento de Oftalmología, Facultad de Medicina, Universidad de Murcia, e Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca), Murcia, Spain.
Juan A Miralles de Imperial-OlleroDepartamento de Oftalmología, Facultad de Medicina, Universidad de Murcia, e Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca), Murcia, Spain.
Manuel Jiménez-LópezDepartamento de Oftalmología, Facultad de Medicina, Universidad de Murcia, e Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca), Murcia, Spain.
María Paz Villegas-PérezDepartamento de Oftalmología, Facultad de Medicina, Universidad de Murcia, e Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca), Murcia, Spain.
Larry A WheelerOphthalmology and Visual Science, University of Utah Health Sciences Center, Salt Lake City, UT, USA.
Manuel Vidal-SanzDepartamento de Oftalmología, Facultad de Medicina, Universidad de Murcia, e Instituto Murciano de Investigación Biosanitaria Virgen de la Arrixaca (IMIB-Arrixaca), Murcia, Spain.
Universidad de Murcia · ESInstituto Murciano de Investigación Biosanitaria · ESKrembil Research InstituteUniversity of Utah · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo develop a focal photoreceptor degeneration model by blue light-emitting diode (LED)-induced phototoxicity (LIP) and investigate the protective effects of topical brimonidine (BMD) or intravitreal brain-derived neurotrophic factor (BDNF), ciliary neurotrophic factor (CNTF), or basic fibroblast growth factor (bFGF).

methodsIn anesthetized, dark-adapted, adult female Swiss mice, the left eye was dilated and exposed to blue light (10 seconds, 200 lux). After LIP, full-field electroretinograms (ERG) and spectral-domain optical coherence tomography (SD-OCT) were obtained longitudinally, and reactive-Iba-1

resultsSD-OCT showed a circular region in the superior-temporal left retina with progressive thinning (207.9 ± 5.6 μm to 160.7 ± 6.8 μm [7 days],

conclusionsLIP is a reliable, quantifiable focal photoreceptor degeneration model. Topical BMD or intravitreal BDNF, CNTF, or bFGF protect against LIP-induced cone-photoreceptor loss. TRANSLATIONAL RELEVANCE: Topical BMD or intravitreal BDNF, CNTF, or bFGF protect cones against phototoxicity.

Indexed as

alpha-2-adrenergic agonistBDNFbFGFBrimonidineCNTFcone photoreceptorslight induced phototoxicitymicroglianeuroprotectionSD-OCT

Identifiers

PMID31890348
PMCPMC6919195
OpenAlexW2996011646

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.